首页> 美国卫生研究院文献>other >Genetically Engineered Virus Nanofibers as an Efficient Vaccine for Preventing Fungal Infection
【2h】

Genetically Engineered Virus Nanofibers as an Efficient Vaccine for Preventing Fungal Infection

机译:基因工程病毒纳米纤维作为预防真菌感染的有效疫苗。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Candida albicans (CA) is a kind of fungi that can cause high morbidity and mortality in immunocompromised patients. However, preventing CA infection in these patients is still a daunting challenge. Herein, inspired from the fact that immunization with Secreted aspartyl proteinases 2 (Sap2) could prevent the infection, we propose to use filamentous phage, a human-safe virus nanofiber specifically infecting bacteria (~900 nm long and 7 nm wide), to display an epitope peptide of Sap2 (EPS, with a sequence of Val-Lys-Tyr-Thr-Ser) on its side wall and thus serve as a vaccine for preventing CA infection. The engineered virus nanofibers and recombinant Sap2 (rSap2) are then separately used to immunize mice. The humoral and cellular immune responses in the immunized mice are evaluated. Surprisingly, the virus nanofibers significantly induce mice to produce strong immune response as rSap2 and generate antibodies that can bind Sap2 and CA to inhibit the CA infection. Consequently, immunization with the virus nanofibers in mice dramatically increase the survival rate of CA-infected mice. All these results, along with the fact that the virus nanofibers can be mass-produced by infecting bacteria cost-effectively, suggest that virus nanofibers displaying EPS can be a vaccine candidate against fungal infection.
机译:白色念珠菌(CA)是一种真菌,可导致免疫受损患者的高发病率和死亡率。然而,在这些患者中预防CA感染仍然是艰巨的挑战。在本文中,受到以下事实的启发:使用分泌的天冬氨酰蛋白酶2(Sap2)进行免疫可以预防感染,我们建议使用丝状噬菌体(一种人类安全的病毒纳米纤维,专门感染细菌(长约900 nm,宽约7 nm))来展示Sap2(EPS,在其侧壁上带有Val-Lys-Tyr-Thr-Ser序列)的抗原决定簇肽,因此可作为预防CA感染的疫苗。然后,将工程化的病毒纳米纤维和重组Sap2(rSap2)分别用于免疫小鼠。评价了免疫小鼠中的体液和细胞免疫应答。令人惊讶的是,病毒纳米纤维显着诱导小鼠产生强免疫反应,如rSap2,并产生可结合Sap2和CA的抗体以抑制CA感染。因此,在小鼠中用病毒纳米纤维免疫大大提高了被CA感染的小鼠的存活率。所有这些结果,加上可以通过经济有效地感染细菌而大量生产病毒纳米纤维这一事实,表明具有EPS的病毒纳米纤维可以作为抗真菌感染的疫苗候选物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号